Showing 1 - 10 of 14
incorporates endogenous product selection within firms. Our findings suggest that product switching contributes to a reallocation …
Persistent link: https://www.econbiz.de/10010745219
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms’ internal drug development capability. We evaluate the effects of M&As on firms’ post-merger R&D...
Persistent link: https://www.econbiz.de/10012227643
When firms engaged in R&D are observably heterogeneous (in size) and policymakers are able to condition policy on the observed heterogeneity, what is the optimal policy? This paper starts with a static two-stage duopoly model of R&D competition with uncertainty and finds it welfare enhancing to...
Persistent link: https://www.econbiz.de/10010841128
We use the establishment level data in the Longitudinal Business Database to measure changes in market structure in the U.S. Retail Trade sector during the period, 1976 to 2000. We use firm ownership information to construct measures of firm entry and exit and also to categorize four types of...
Persistent link: https://www.econbiz.de/10005058611
In the last decades the world has seen some acceleration in the process of internationalization, affecting virtually all industries. The wine sector is no exception, witnessing increased exports and imports and a movement of mergers and acquisitions. Among European wines, Port Wine can be seen...
Persistent link: https://www.econbiz.de/10005607473
This paper develops a framework to appreciate the observed heterogeneity of firm size distributions and the entry and exit of products and firms associated with it. It is based on a model where new products are introduced by innovating firms in a quasi-temporal setting of monopolistic...
Persistent link: https://www.econbiz.de/10008626064
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D...
Persistent link: https://www.econbiz.de/10012219372
We estimate a model that allows for dynamic and interdependent responses of morbidity in different local areas to economic conditions at the local and national level, with statistical selection of optimal local area. We apply this approach to quarterly British data on chronic health conditions...
Persistent link: https://www.econbiz.de/10012207772
We study an optimal growth model with one-hoss-shay vintage capital, where labor resources can be allocated freely either to production, technology adoption or capital maintenance. Technological progress is partly embodied. Adoption labor increases the level of embodied technical progress....
Persistent link: https://www.econbiz.de/10005042981
Money, which provides liquidity services, is distinct from debt. The introduction of a bank that issues money in exchange for debt and pays out its profit as dividend to shareholders modifies the model of overlapping generations. The set of equilibrium paths, their dynamic properties, as well as...
Persistent link: https://www.econbiz.de/10005043640